Thelansis

  Clearmind Medicine Inc., a clinical-stage biotech company dedicated to the discovery and development of innovative psychedelic-derived therapeutics for major under-treated health issues, has received Institutional Review Board (IRB) approval for part A of its Phase I/IIa clinical trial in the United States. This trial aims to treat patients suffering from alcohol use disorder (AUD) using their novel compound, CMND-100. The approval marks a significant step forward in Clearmind Medicine's mission to provide effective treatments for those struggling with AUD. Publish Date: 10-10-2024   Source: Clearmind Medicine Inc. Alcohol Use Disorder (AUD) is a pathological condition characterized by persistent and excessive alcohol consumption, leading to a diminished ability to limit or abstain from alcohol use despite adverse consequences in one's social, occupational, or medical domain. The disease is characterized by several key symptoms, including: Craving - an intense ...

  Alcohol Use Disorder (AUD) is a pathological condition characterized by persistent and excessive alcohol consumption, leading to a diminished ability to limit or abstain from alcohol use despite adverse consequences in one's social, occupational, or medical domain. The disease is characterized by several key symptoms, including: 1. Craving - an intense urge to consume alcohol 2. Loss of control - an inability to cease alcohol consumption once initiated 3. Negative emotional state - feelings of anxiety and irritability when abstaining from alcohol. Several factors increase the chances of developing an alcohol use disorder, such as Family history of substance abuse and alcohol use disorder, Accessibility of alcohol, Excessive alcohol consumption, Binge drinking, Permissive cultural attitudes towards alcohol, Childhood abuse, Childhood conduct or mood disorders, Co-occurring mental health conditions such as depression and PTSD, Impulsivity. Diagnosis of AUD is made through a compr...

 Alcohol Use Disorder (AUD) is a pathological condition characterized by persistent and excessive alcohol consumption, leading to a diminished ability to limit or abstain from alcohol use despite adverse consequences in one's social, occupational, or medical domain. The disease is characterized by several key symptoms, including: 1. Craving - an intense urge to consume alcohol 2. Loss of control - an inability to cease alcohol consumption once initiated 3. Negative emotional state - feelings of anxiety and irritability when abstaining from alcohol. Several factors increase the chances of developing an alcohol use disorder, such as Family history of substance abuse and alcohol use disorder, Accessibility of alcohol, Excessive alcohol consumption, Binge drinking, Permissive cultural attitudes towards alcohol, Childhood abuse, Childhood conduct or mood disorders, Co-occurring mental health conditions such as depression and PTSD, Impulsivity. Diagnosis of AUD is made through a comprehe...